Fragment screen against ABLE
Correy, G.J., Fraser, J.S.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
De novo designed ABLE protein | 126 | synthetic construct | Mutation(s): 0  | ![]() | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
6U6 Query on 6U6 | B [auth A] | 3-(5-chloranyl-1,3-benzothiazol-2-yl)propanoic acid C10 H8 Cl N O2 S UMBLVHSXXWQLDL-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 26.212 | α = 90 |
b = 46.969 | β = 103.65 |
c = 46.625 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
Aimless | data scaling |
PDB_EXTRACT | data extraction |
XDS | data reduction |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) | United States | GM145238 |